• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像指数预测克罗恩病术后复发:MONITOR 指数。

A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index.

机构信息

Department of Hepatogastroenterology, Nancy University Hospital, Vandoeuvre-lès-Nancy.

Central Department of Radiology, Nancy University Hospital, Vandoeuvre-lès-Nancy.

出版信息

Clin Gastroenterol Hepatol. 2022 May;20(5):e1040-e1049. doi: 10.1016/j.cgh.2021.06.035. Epub 2021 Jun 30.

DOI:10.1016/j.cgh.2021.06.035
PMID:34216820
Abstract

BACKGROUND & AIMS: We developed and validated a magnetic resonance imaging-based index to predict Crohn's disease (CD) postoperative recurrence (POR).

METHODS

Patients with CD who underwent a postoperative evaluation for recurrence (with colonoscopy and MRI no longer than 105 days apart) were included between 2006 and 2016 in University Hospital of Nancy, France. MRI items with good levels of intra-rater and inter-rater agreement (Gwet's coefficient ≥0.5) were selected. The MRI in Crohn's Disease to Predict Postoperative Recurrence (MONITOR) index's performance was assessed in terms of the area under the receiver operating characteristic curve (AUROC) and accuracy, by considering the Rutgeerts score as the gold standard. The MONITOR index was validated with a bootstrap method and an independent cohort.

RESULTS

Seventy-three MRI datasets were interpreted by 2 radiologists. Seven items (bowel wall thickness, contrast enhancement, T2 signal increase, diffusion-weighted signal increase, edema, ulcers, and the length of the diseased segment) had a Gwet's coefficient ≥0.5 and were significantly associated with the Rutgeerts score, leading to their inclusion in the MONITOR index. All the items had a weighting of 1, except the "ulcers" item weighting 2.5, reflecting the higher adjusted odds ratio. The AUROC [95% confidence interval] for the prediction of endoscopic POR (Rutgeerts score >i1) was 0.80 [0.70-0.90]. The optimal threshold was a MONITOR index ≥1, giving a sensitivity of 79%, a specificity of 55%, a predictive positive value of 68%, and a predictive negative value of 68%. The bootstrap validation gave an AUROC of 0.85 [0.73-0.97]. In the validation cohort, a MONITOR index ≥1 gave a sensitivity of 87%, a specificity of 75%, a predictive positive value of 84.6%, and a predictive negative value of 75%.

CONCLUSIONS

The MONITOR index is an efficient, reliable, easy-to-apply tool that can be used in clinical practice to predict the POR of CD.

摘要

背景与目的

我们开发并验证了一种基于磁共振成像的指数,用于预测克罗恩病(CD)术后复发(POR)。

方法

纳入 2006 年至 2016 年期间在法国南锡大学医院接受术后复发评估(结肠镜检查和 MRI 检查时间不超过 105 天)的 CD 患者。选择具有良好的内部和外部观察者一致性(Gwet 系数≥0.5)的 MRI 项目。根据 Rutgeerts 评分作为金标准,评估磁共振成像克罗恩病术后复发预测(MONITOR)指数的表现,包括接收者操作特征曲线(AUROC)和准确性。通过 bootstrap 方法和独立队列对 MONITOR 指数进行验证。

结果

两名放射科医生共解读了 73 份 MRI 数据集。7 项(肠壁厚度、对比增强、T2 信号增加、弥散加权信号增加、水肿、溃疡和病变段长度)具有 Gwet 系数≥0.5,与 Rutgeerts 评分显著相关,因此被纳入 MONITOR 指数。所有项目的权重均为 1,除了“溃疡”项目权重为 2.5,反映了更高的调整后比值比。内镜 POR(Rutgeerts 评分>i1)预测的 AUROC[95%置信区间]为 0.80[0.70-0.90]。最佳阈值为 MONITOR 指数≥1,灵敏度为 79%,特异性为 55%,阳性预测值为 68%,阴性预测值为 68%。bootstrap 验证的 AUROC 为 0.85[0.73-0.97]。在验证队列中,MONITOR 指数≥1 的灵敏度为 87%,特异性为 75%,阳性预测值为 84.6%,阴性预测值为 75%。

结论

MONITOR 指数是一种高效、可靠、易于应用的工具,可用于临床实践中预测 CD 的 POR。

相似文献

1
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index.磁共振成像指数预测克罗恩病术后复发:MONITOR 指数。
Clin Gastroenterol Hepatol. 2022 May;20(5):e1040-e1049. doi: 10.1016/j.cgh.2021.06.035. Epub 2021 Jun 30.
2
Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.粪便钙卫蛋白和磁共振成像检测克罗恩病内镜术后复发。
World J Gastroenterol. 2018 Feb 7;24(5):641-650. doi: 10.3748/wjg.v24.i5.641.
3
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.鲁杰尔斯评分、SES-CD和MM-SES-CD对克罗恩病术后临床复发的预测性能
Inflamm Bowel Dis. 2023 May 2;29(5):716-725. doi: 10.1093/ibd/izac130.
4
Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.内镜预测克罗恩病术后复发。
Inflamm Bowel Dis. 2022 May 4;28(5):680-688. doi: 10.1093/ibd/izab134.
5
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.磁共振成像评估克罗恩病:严重程度参数和活动定量指标的验证。
Inflamm Bowel Dis. 2011 Aug;17(8):1759-68. doi: 10.1002/ibd.21551. Epub 2010 Nov 8.
6
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
7
A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.一种新的粪便钙卫蛋白快速检测可预测克罗恩病的内镜缓解和术后复发。
J Crohns Colitis. 2013 Dec;7(12):e641-51. doi: 10.1016/j.crohns.2013.05.005. Epub 2013 Jul 1.
8
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease.术后 3 个月内粪便钙卫蛋白水平的变化可预测克罗恩病肠切除术后内镜下复发。
Dig Liver Dis. 2020 Jul;52(7):740-744. doi: 10.1016/j.dld.2020.03.020. Epub 2020 May 20.
9
Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease.粪便钙卫蛋白水平与克罗恩病术后相关黏膜病变的缺失密切相关。
Inflamm Bowel Dis. 2016 Dec;22(12):2879-2885. doi: 10.1097/MIB.0000000000000960.
10
Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn's disease.对比增强超声:在评估克罗恩病术后复发中的应用价值。
J Crohns Colitis. 2013 Apr;7(3):192-201. doi: 10.1016/j.crohns.2012.03.017. Epub 2012 Apr 26.

引用本文的文献

1
Evaluating luminal and post-operative Crohn's disease activity on magnetic resonance enterography: A review of radiological disease activity scores.磁共振小肠造影评估管腔型及术后克罗恩病的活动度:放射学疾病活动度评分综述
World J Gastroenterol. 2025 Jul 14;31(26):107419. doi: 10.3748/wjg.v31.i26.107419.
2
Optimizing Biologic Therapy for the Prevention of Post-Operative Recurrence in Crohn's Disease: Current Evidence and Future Perspectives.优化生物疗法预防克罗恩病术后复发:当前证据与未来展望
Biomedicines. 2025 May 19;13(5):1232. doi: 10.3390/biomedicines13051232.
3
MR enterography radiologic ulcers in newly diagnosed ileal Crohn disease in children: frequency, inter-radiologist agreement, and clinical correlation.
磁共振肠造影术在儿童新诊断回肠克罗恩病中的放射学溃疡:频率、放射科医生间的一致性和临床相关性。
Pediatr Radiol. 2024 Oct;54(11):1842-1849. doi: 10.1007/s00247-024-06056-7. Epub 2024 Sep 18.
4
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature.克罗恩病:临床问题的放射学解答及文献综述
J Clin Med. 2024 Jul 16;13(14):4145. doi: 10.3390/jcm13144145.
5
Diagnostic value of MR and CT enterography in post-operative recurrence of Crohn's disease: a systematic review and meta-analysis.磁共振和 CT 肠造影术对克罗恩病术后复发的诊断价值:系统评价和荟萃分析。
Abdom Radiol (NY). 2024 Nov;49(11):3975-3986. doi: 10.1007/s00261-024-04394-6. Epub 2024 Jun 3.
6
The Management of Postoperative Recurrence in Crohn's Disease.克罗恩病术后复发的管理
J Clin Med. 2023 Dec 25;13(1):119. doi: 10.3390/jcm13010119.
7
Precision medicine and drug optimization in adult inflammatory bowel disease patients.成人炎症性肠病患者的精准医学与药物优化
Therap Adv Gastroenterol. 2023 May 10;16:17562848231173331. doi: 10.1177/17562848231173331. eCollection 2023.
8
Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn's Disease: Are We There Yet?用磁共振小肠造影取代内镜检查评估末端回肠克罗恩病的黏膜活性:我们做到了吗?
Diagnostics (Basel). 2023 Mar 10;13(6):1061. doi: 10.3390/diagnostics13061061.
9
Use of imaging modalities for decision-making in inflammatory bowel disease.炎症性肠病决策中成像模态的应用。
Therap Adv Gastroenterol. 2023 Feb 9;16:17562848231151293. doi: 10.1177/17562848231151293. eCollection 2023.
10
Inflammatory bowel disease cross-sectional imaging: What's new?炎症性肠病的横断面成像:有哪些新进展?
United European Gastroenterol J. 2022 Dec;10(10):1179-1193. doi: 10.1002/ueg2.12343. Epub 2022 Dec 3.